IMAX CORP (IMAX) Stock Fundamental Analysis

NYSE:IMAX • CA45245E1097

37.64 USD
-0.16 (-0.42%)
Last: Feb 19, 2026, 03:10 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, IMAX scores 6 out of 10 in our fundamental rating. IMAX was compared to 80 industry peers in the Entertainment industry. IMAX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IMAX is not valued too expensively and it also shows a decent growth rate. With these ratings, IMAX could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year IMAX was profitable.
  • IMAX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
  • Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • IMAX's Return On Assets of 4.45% is amongst the best of the industry. IMAX outperforms 82.50% of its industry peers.
  • IMAX has a Return On Equity of 11.31%. This is amongst the best in the industry. IMAX outperforms 83.75% of its industry peers.
  • IMAX has a Return On Invested Capital of 7.73%. This is amongst the best in the industry. IMAX outperforms 83.75% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for IMAX is below the industry average of 7.77%.
  • The 3 year average ROIC (4.23%) for IMAX is below the current ROIC(7.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROIC 7.73%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • IMAX's Profit Margin of 10.47% is amongst the best of the industry. IMAX outperforms 86.25% of its industry peers.
  • IMAX's Profit Margin has declined in the last couple of years.
  • IMAX has a better Operating Margin (19.91%) than 91.25% of its industry peers.
  • IMAX's Operating Margin has declined in the last couple of years.
  • IMAX's Gross Margin of 58.89% is fine compared to the rest of the industry. IMAX outperforms 66.25% of its industry peers.
  • In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • IMAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, IMAX has less shares outstanding
  • Compared to 5 years ago, IMAX has less shares outstanding
  • Compared to 1 year ago, IMAX has a worse debt to assets ratio.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 2.83 indicates that IMAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.83, IMAX is doing good in the industry, outperforming 76.25% of the companies in the same industry.
  • IMAX has a debt to FCF ratio of 2.85. This is a good value and a sign of high solvency as IMAX would need 2.85 years to pay back of all of its debts.
  • The Debt to FCF ratio of IMAX (2.85) is better than 81.25% of its industry peers.
  • A Debt/Equity ratio of 0.74 indicates that IMAX is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.74, IMAX is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Altman-Z 2.83
ROIC/WACC0.92
WACC8.4%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • IMAX has a Current Ratio of 2.47. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
  • IMAX's Current ratio of 2.47 is fine compared to the rest of the industry. IMAX outperforms 80.00% of its industry peers.
  • IMAX has a Quick Ratio of 2.12. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.12, IMAX is in the better half of the industry, outperforming 77.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.12
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.94% over the past year.
  • Measured over the past years, IMAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.17% on average per year.
  • IMAX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
  • IMAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.30% yearly.
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.24% on average over the next years. This is a very strong growth
  • IMAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y44.59%
EPS Next 2Y33.81%
EPS Next 3Y25.83%
EPS Next 5Y25.24%
Revenue Next Year11.79%
Revenue Next 2Y10.33%
Revenue Next 3Y9.45%
Revenue Next 5Y6.43%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • IMAX is valuated quite expensively with a Price/Earnings ratio of 33.31.
  • 78.75% of the companies in the same industry are more expensive than IMAX, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.27. IMAX is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 22.13, which indicates a rather expensive current valuation of IMAX.
  • IMAX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IMAX is cheaper than 80.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.16. IMAX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 33.31
Fwd PE 22.13
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMAX is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, IMAX is valued cheaper than 81.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.44
EV/EBITDA 15.83
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of IMAX may justify a higher PE ratio.
  • A more expensive valuation may be justified as IMAX's earnings are expected to grow with 25.83% in the coming years.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y33.81%
EPS Next 3Y25.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMAX CORP

NYSE:IMAX (2/19/2026, 3:10:05 PM)

37.64

-0.16 (-0.42%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-23
Earnings (Next)02-25
Inst Owners93%
Inst Owner Change-9.85%
Ins Owners19.21%
Ins Owner Change-0.2%
Market Cap2.03B
Revenue(TTM)377.68M
Net Income(TTM)39.55M
Analysts82.22
Price Target45.22 (20.14%)
Short Float %14.09%
Short Ratio4.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.48%
Min EPS beat(2)20.24%
Max EPS beat(2)20.72%
EPS beat(4)3
Avg EPS beat(4)11.61%
Min EPS beat(4)-6.42%
Max EPS beat(4)20.72%
EPS beat(8)7
Avg EPS beat(8)65.63%
EPS beat(12)10
Avg EPS beat(12)54.13%
EPS beat(16)11
Avg EPS beat(16)15.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.56%
Revenue beat(12)6
Avg Revenue beat(12)1.35%
Revenue beat(16)7
Avg Revenue beat(16)2.11%
PT rev (1m)3.3%
PT rev (3m)17.7%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.57%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 33.31
Fwd PE 22.13
P/S 5.36
P/FCF 22.44
P/OCF 18.55
P/B 5.79
P/tB 8.06
EV/EBITDA 15.83
EPS(TTM)1.13
EY3%
EPS(NY)1.7
Fwd EY4.52%
FCF(TTM)1.68
FCFY4.46%
OCF(TTM)2.03
OCFY5.39%
SpS7.02
BVpS6.5
TBVpS4.67
PEG (NY)0.75
PEG (5Y)N/A
Graham Number12.85
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROCE 9.75%
ROIC 7.73%
ROICexc 9.49%
ROICexgc 14.13%
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
FCFM 23.9%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Debt/EBITDA 1.9
Cap/Depr 31.29%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 80.47%
Profit Quality 228.24%
Current Ratio 2.47
Quick Ratio 2.12
Altman-Z 2.83
F-Score8
WACC8.4%
ROIC/WACC0.92
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
EPS Next Y44.59%
EPS Next 2Y33.81%
EPS Next 3Y25.83%
EPS Next 5Y25.24%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%
Revenue Next Year11.79%
Revenue Next 2Y10.33%
Revenue Next 3Y9.45%
Revenue Next 5Y6.43%
EBIT growth 1Y94.17%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year239.35%
EBIT Next 3Y62.36%
EBIT Next 5Y38.42%
FCF growth 1Y52.72%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y52.91%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%

IMAX CORP / IMAX FAQ

Can you provide the ChartMill fundamental rating for IMAX CORP?

ChartMill assigns a fundamental rating of 6 / 10 to IMAX.


Can you provide the valuation status for IMAX CORP?

ChartMill assigns a valuation rating of 6 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 7 / 10.


What is the earnings growth outlook for IMAX CORP?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 44.59% in the next year.